DE60216952D1 - Beta-carbolin-derivate als ptp-inhibitoren - Google Patents
Beta-carbolin-derivate als ptp-inhibitorenInfo
- Publication number
- DE60216952D1 DE60216952D1 DE60216952T DE60216952T DE60216952D1 DE 60216952 D1 DE60216952 D1 DE 60216952D1 DE 60216952 T DE60216952 T DE 60216952T DE 60216952 T DE60216952 T DE 60216952T DE 60216952 D1 DE60216952 D1 DE 60216952D1
- Authority
- DE
- Germany
- Prior art keywords
- diseases
- inhibitors
- ptpases
- diabetes
- useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- AIDS & HIV (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34612501P | 2001-10-19 | 2001-10-19 | |
US34617601P | 2001-10-19 | 2001-10-19 | |
US346125P | 2001-10-19 | ||
US346176P | 2001-10-19 | ||
PCT/US2002/033520 WO2003033496A1 (en) | 2001-10-19 | 2002-10-18 | Beta-carbolin derivatives as ptp-inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60216952D1 true DE60216952D1 (de) | 2007-02-01 |
DE60216952T2 DE60216952T2 (de) | 2007-07-05 |
Family
ID=26994711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60216952T Expired - Fee Related DE60216952T2 (de) | 2001-10-19 | 2002-10-18 | Beta-carbolin-derivate als ptp-inhibitoren |
Country Status (9)
Country | Link |
---|---|
US (2) | US6933303B2 (de) |
EP (1) | EP1438310B1 (de) |
JP (1) | JP2005508968A (de) |
AT (1) | ATE348828T1 (de) |
DE (1) | DE60216952T2 (de) |
DK (1) | DK1438310T3 (de) |
ES (1) | ES2278064T3 (de) |
HK (1) | HK1067128A1 (de) |
WO (1) | WO2003033496A1 (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PA8586801A1 (es) | 2002-10-31 | 2005-02-04 | Pfizer | Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso |
EP1590349A1 (de) | 2003-01-27 | 2005-11-02 | Pfizer Inc. | Hiv-integrase-inhibitoren, pharmazeutische zusammensetzung, und verfahren zu deren anwendung |
WO2004071448A2 (en) * | 2003-02-12 | 2004-08-26 | Transtech Pharma Inc. | Substituted azole derivatives as inhibitors of protein tyrosine phosphatases |
EP1594847A2 (de) * | 2003-02-12 | 2005-11-16 | Transtech Pharma, Inc. | Substituierte azolderivate zur therapeutischen verwendung |
US7459472B2 (en) * | 2003-08-08 | 2008-12-02 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions, and methods of use |
AU2004263508A1 (en) | 2003-08-08 | 2005-02-17 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions, and methods of use |
WO2005035551A2 (en) | 2003-10-08 | 2005-04-21 | Incyte Corporation | Inhibitors of proteins that bind phosphorylated molecules |
WO2005063748A1 (en) * | 2003-12-31 | 2005-07-14 | Council Of Scientific And Industrial Research | β-CARBOLINE DERIVED GUANIDINE ALKALOID, TIRUCHENDURAMINE |
CN1910183A (zh) | 2004-01-23 | 2007-02-07 | 希龙公司 | 四氢咔啉化合物作为抗癌药 |
CA2551909C (en) * | 2004-02-12 | 2011-10-11 | Transtech Pharma, Inc. | Substituted azole derivatives, compositions, and methods of use |
UA92317C2 (ru) * | 2004-03-15 | 2010-10-25 | Пи-Ти-Си ТЕРАПЬЮТИКС, ИНК. | Производные карболина, пригодные для ингибирования развития кровеносных сосудов |
US8076353B2 (en) | 2004-03-15 | 2011-12-13 | Ptc Therapeutics, Inc. | Inhibition of VEGF translation |
US7767689B2 (en) * | 2004-03-15 | 2010-08-03 | Ptc Therapeutics, Inc. | Carboline derivatives useful in the treatment of cancer |
US8076352B2 (en) | 2004-03-15 | 2011-12-13 | Ptc Therapeutics, Inc. | Administration of carboline derivatives useful in the treatment of cancer and other diseases |
US7626025B2 (en) | 2004-03-30 | 2009-12-01 | Council Of Scientific And Industrial Research | Beta-carboline derived guanidine alkaloids, tiruchenduramine |
BRPI0510319A (pt) | 2004-04-26 | 2007-10-16 | Pfizer | inibidores da enzima integrase de hiv |
EP1751157B1 (de) | 2004-04-26 | 2007-10-03 | Pfizer Inc. | Inhibitoren des hiv-integrase-enzyms |
CN1976930B (zh) * | 2004-05-17 | 2011-01-19 | 泰博特克药品有限公司 | 用作抗感染药物的6,7,8,9-取代的1-苯基-1,5-二氢吡啶并(3,2-b)吲哚-2-酮 |
BRPI0511874A (pt) | 2004-06-09 | 2008-01-15 | Glaxo Group Ltd | derivados da pirrolopiridina |
EP1991544B1 (de) | 2006-01-30 | 2018-08-15 | vTv Therapeutics LLC | Substituierte imidazol- derivate und ihre verwendung als ptpase inhibitoren |
EP2178537A4 (de) * | 2007-07-19 | 2011-08-17 | Merck Sharp & Dohme | Beta-carbolin-derivate als antidiabetische verbindungen |
WO2009118259A1 (en) * | 2008-03-25 | 2009-10-01 | Merck Serono S.A. | Ptph1 inhibitors for the treatment of alzheimer's disease |
MA33219B1 (fr) | 2009-03-30 | 2012-04-02 | Transtech Pharma Inc | Derives d'azoanthracene substitues, compositions pharmaceutiques et leurs procedes d'utilisation |
US8697662B2 (en) | 2009-05-27 | 2014-04-15 | Ptc Therapeutics, Inc. | Methods for treating Kaposi sarcoma |
TWI671297B (zh) | 2009-05-27 | 2019-09-11 | Ptc治療公司 | 治療癌症及非腫瘤病症之方法 |
US8703726B2 (en) | 2009-05-27 | 2014-04-22 | Ptc Therapeutics, Inc. | Methods for treating prostate conditions |
CN102459263A (zh) | 2009-05-27 | 2012-05-16 | Ptc医疗公司 | 取代的四氢β-咔啉的制备工艺 |
US20100323979A1 (en) * | 2009-06-16 | 2010-12-23 | Weis-Amon Angelika B | Methods and compositions for inhibiting proliferation of aneuploid cells |
US9169247B2 (en) | 2009-11-20 | 2015-10-27 | Southern Research Institute | Tetrahydro-beta-carboline derivatives, synthesis and use thereof |
TW201309698A (zh) | 2011-03-18 | 2013-03-01 | Ono Pharmaceutical Co | 四氫咔啉衍生物 |
CN102391323B (zh) * | 2011-10-18 | 2013-09-25 | 首都医科大学 | 四氢-β-咔啉衍生物、其制备方法及其用途 |
CN103159758B (zh) * | 2011-12-13 | 2015-08-05 | 首都医科大学 | (1S,3S)-1-对硝基苯基-1,2,3,4-四氢-β-咔啉酰氨基酸、其合成、抗栓活性和作为抗血栓剂的应用 |
US20150018369A1 (en) * | 2012-01-09 | 2015-01-15 | University Of Washington Through Its Center For Commercialization | Compositions and Methods for Treating Malignant Astrocytomas |
CN105153277A (zh) * | 2014-06-11 | 2015-12-16 | 首都医科大学 | KE修饰的β-咔啉,其制备,纳米结构,活性和应用 |
IL295050A (en) | 2016-04-01 | 2022-09-01 | Recurium Ip Holdings Llc | Estrogen receptor modulators |
US11289654B2 (en) | 2016-12-22 | 2022-03-29 | Guangzhou Chinaray Optoelectronic Materials Ltd. | Polymers containing furanyl crosslinkable groups and uses thereof |
WO2018130123A1 (zh) * | 2017-01-11 | 2018-07-19 | 南京圣和药业股份有限公司 | 作为选择性雌激素受体下调剂的五环类化合物及其应用 |
WO2019028171A1 (en) | 2017-08-01 | 2019-02-07 | Ptc Therapeutics, Inc. | DHODH INHIBITOR FOR USE IN THE TREATMENT OF HEMATOLOGICAL CANCERS |
JP2022543832A (ja) | 2019-08-06 | 2022-10-14 | リキュリウム アイピー ホールディングス リミテッド ライアビリティー カンパニー | 変異体を治療するためのエストロゲン受容体調節剤 |
EP4267578A1 (de) | 2020-12-23 | 2023-11-01 | Recurium IP Holdings, LLC | Östrogenrezeptormodulatoren |
WO2024039861A1 (en) * | 2022-08-19 | 2024-02-22 | Olema Pharmaceuticals, Inc. | 2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indole derivatives as estrogen receptor modulators for the treatment of cancer |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5244905A (en) * | 1990-08-31 | 1993-09-14 | Warner-Lambert Company | N-substituted cycloalkyl and polycycloalkyl polyhydro-β-carboline-phenylalanine- and phenethylamine derivatives |
US5770620A (en) * | 1995-06-19 | 1998-06-23 | Ontogen Corporation | Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
US6388076B1 (en) * | 1995-06-19 | 2002-05-14 | Ontogen Corporation | Protein tyrosine phosphatase-inhibiting compounds |
DK0891187T3 (da) * | 1996-04-04 | 2002-04-29 | Hoffmann La Roche | Anvendelse af tetrahydro-beta-carbolin-derivater som antimetastatiske midler |
AU8071698A (en) * | 1997-06-13 | 1998-12-30 | Sugen, Inc. | Novel heteroaryl compounds for the modulation of protein tyrosine enzyme relatedcellular signal transduction |
AU2713799A (en) * | 1998-03-12 | 1999-09-27 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (ptpases) |
-
2002
- 2002-10-18 JP JP2003536235A patent/JP2005508968A/ja active Pending
- 2002-10-18 DE DE60216952T patent/DE60216952T2/de not_active Expired - Fee Related
- 2002-10-18 DK DK02780494T patent/DK1438310T3/da active
- 2002-10-18 AT AT02780494T patent/ATE348828T1/de not_active IP Right Cessation
- 2002-10-18 US US10/274,546 patent/US6933303B2/en not_active Expired - Fee Related
- 2002-10-18 EP EP02780494A patent/EP1438310B1/de not_active Expired - Lifetime
- 2002-10-18 WO PCT/US2002/033520 patent/WO2003033496A1/en active IP Right Grant
- 2002-10-18 ES ES02780494T patent/ES2278064T3/es not_active Expired - Lifetime
-
2004
- 2004-12-15 US US11/012,636 patent/US20050096335A1/en not_active Abandoned
-
2005
- 2005-01-13 HK HK05100283A patent/HK1067128A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2003033496A1 (en) | 2003-04-24 |
US20050096335A1 (en) | 2005-05-05 |
EP1438310A1 (de) | 2004-07-21 |
US6933303B2 (en) | 2005-08-23 |
US20040014778A1 (en) | 2004-01-22 |
HK1067128A1 (en) | 2005-04-01 |
DE60216952T2 (de) | 2007-07-05 |
ATE348828T1 (de) | 2007-01-15 |
EP1438310B1 (de) | 2006-12-20 |
DK1438310T3 (da) | 2007-03-26 |
ES2278064T3 (es) | 2007-08-01 |
JP2005508968A (ja) | 2005-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60216952D1 (de) | Beta-carbolin-derivate als ptp-inhibitoren | |
TW200700068A (en) | Phthalazine, aza-and diaza-phthalazine compounds and methods of use | |
UA83194C2 (ru) | Производные пиримидина и их применение как модуляторов св2 | |
NO20021358D0 (no) | Alkylendiamin-substituerte heterocykler | |
NO20030845D0 (no) | Utvalgte fusjonerte pyrrolokarbazoler | |
AU2003282234A1 (en) | Benzofuran derivates, process for their preparation and intermediates thereof | |
RS20050363A (en) | Chk-,pdk-and akt-inhibitory pyrimidines,their production an use as pharmaceutical agents | |
PT1206474E (pt) | Compostos de sulfonilfenilpirazole uteis como inibidores de cox-2 | |
WO2004071448A3 (en) | Substituted azole derivatives as inhibitors of protein tyrosine phosphatases | |
AU2003209118A1 (en) | Aryl ureas as kinase inhibitors | |
ATE512147T1 (de) | Makrozyklische aminiopyridyl-beta-sekretase- hemmer zur behandlung von morbus alzheimer | |
MXPA03006749A (es) | Proceso para la sintesis de compuestos de urea sustituidos con heteroarilo, utiles como agentes antiinflamatorios. | |
SG149045A1 (en) | Novel fused pyrrolocarbazoles | |
SG149042A1 (en) | Novel fused pyrrolocarbazoles | |
ATE437855T1 (de) | (4,5,6,7-tetrahydro-1h-indol-7- yl)essigsäurederivate zur behandlung von alzheimer-krankheit | |
AU2003260436A1 (en) | Pyrimidine compounds | |
DE602004007672D1 (de) | Zur behandlung von zns-erkrankungen geeignete piperazinylchinolinderivate | |
EP1812007A4 (de) | Pyridazinverbindungen und verfahren | |
DE60015508T2 (de) | C-16 ungesätigte fp-selektive prostaglandin analoge | |
DK1441724T3 (da) | Fremgangsmåde til forögelse af endogene testosteronniveauer | |
BRPI0415355A (pt) | triarilimidazóis | |
ATE320255T1 (de) | Tie2 rezeptor-kinase-inhibitoren zur behandlung von angiogenen erkrankungen | |
ATE267194T1 (de) | Medikamente geeignet zur behandlung von proliferativen erkrankungen | |
ATE423780T1 (de) | Makrozyclen zur behandlung von krebserkrankungen | |
DE60219495D1 (de) | Verwendung von Interleukin-18 zur Behandlung von UV-assoziierten Hautkrankheiten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |